Niagen Bioscience shares are trading up 2.54% at $13.75 at the time of this writing on Thursday morning. Since the current price is $13.75, this makes Cohen's 0 shares worth $0.

Minovia’s lead product is MNV-201, an autologous hematopoietic stem cell product that is enriched with allogeneic ...

As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical ...

COIN and CRCLE are some of the US crypto stocks surging after the GENIUS Act passed, signaling strong growth in the crypto ...

FibroBiologics, Inc., a clinical-stage biotechnology company specializing in fibroblast-based therapies, announced that CEO Pete O’Heeron will present a company update at the BIO International ...

Instil Bio, Inc. (TIL) closed the last trading session at $34.23, gaining 134% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and ...

The grants were approved by the Compensation Committee and made as an inducement material to each employee entering into employment with EyePoint in accordance with NASDAQ Listing Rule 5635(c)(4). The ...

The Inducement Grants were granted pursuant to Aligos’ 2024 Inducement Plan (the “Plan”) as an inducement material to these individuals entering employment in accordance with Nasdaq Listing Rule ...

Highlights: Over $11 Million Raised: Proceeds were generated through the exercise of existing warrants. Chardan Capital Markets was the exclusive financial advisor in connection with public warrant ...

Our analyst team just revealed what they believe are the 10 best stocks to buy right now. ... (IPO) in 1994, Realty Income stock has risen a little faster than the S&P 500 index.